Coherus BioSciences | 8-K: Current report
Coherus BioSciences | 8-K: Coherus BioSciences Reports Fourth Quarter, Full Year 2024 Financial Results and Provides Business Update
Coherus BioSciences | DEFA14A: Others
Coherus BioSciences | 8-K: Current report
Coherus BioSciences | SCHEDULE 13G/A: Others
Coherus BioSciences | SCHEDULE 13G/A: Others
Coherus BioSciences | DEFA14A: Others
Coherus BioSciences | DEFM14A: Definitive proxy statement relating to merger or acquisition
Coherus BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer McMichael Bryan J
Coherus BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer Reider Paul
Coherus BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer Lanfear Dennis M
Coherus BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer Lanfear Dennis M
Coherus BioSciences | PREM14A: Preliminary proxy statements relating to merger or acquisition
Coherus BioSciences | DEFA14A: Others
Coherus BioSciences | 8-K: Current report
Coherus BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer McMichael Bryan J
Coherus BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer Lanfear Dennis M
Coherus BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer McMichael Bryan J
Coherus BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer Reider Paul
Coherus BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer Reider Paul